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Abstract The importance of high transfection efficiency has been emphasized in many studies investigating 
methods to improve gene delivery. Accordingly, non-viral transfection agents are widely used as transfection 
vectors to condense oligonucleotides, DNA, RNA, siRNA, deliver into the cell, and release the cargo. 
Polyethyleneimine (PEI) is one of the most popular non-viral transfection agents. However, the challenge 
between high transfection efficiency and toxicity of the polymers is not totally resolved. The delivery of 
necessary drugs and genes for patients and their transport under safe conditions require carefully designed 
and controlled delivery systems and constitute a critical stage of patients’ treatment. Compact systems are 
considered as the strongest candidate for the preparation and delivery of drugs and genes under leak free and 
safe conditions because of their low energy consumption, low waste disposal, parallel and fast processing 
capabilities, removal of human factor, high mixing capabilities, enhanced safety, and low amount of 
reagents. Motivated by this need in the literature, a platform for gene delivery via magnetic actuation of 
nanoparticles was developed in this study. The use of PEI-SPION (Super paramagnetic ironoxide 
nanoparticles) as transfection agents in in vitro studies  was investigated with the effect of varying magnetic 
fields provided by a special magnetic system design, which was used as magnetic actuator offering different 
magnet's turn speeds and directions in the system. Results obtained from magnetic actuator systems were 
compared to the experiments without actuation and significant enhancement was observed in the transfection 
efficacies. 
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1. Introduction 
  
 Magnetofection is a basic and very 
efficient transfection technique which uses 
magnetic fields to concentrate nucleic acid-
containing-nanoparticles into target cells. 
Classical transfection methods, including 
cationic lipids, polymers, electroporation and 
gene gun, were used with some limitations 
such as low efficiency and toxicity. 
Additionally, slow vector accumulation and 
consequently low vector concentration at 
target tissues were identified as strong barriers 
to effective viral or non-viral gene delivery 
[Luo D, Saltzman WM. Enhancement of 
transfection by physical concentration of DNA 
at the cell surface]. In terms of overcoming 
these inconveniences, magnetofection provides 
an alternative way of targeted gene delivery 
using magnetic fields.  As a result, many 
studies related to gene delivery via 
magnetofection are now available in the 
literature [1-11]. For example, Scherer et al. 
[1] coupled gene vectors with super-
paramagnetic nanoparticles and targeted gene 
delivery by application of magnetic field to 
accomplish the difficulties of viral or non-viral 
gene therapy. They succeed to decrease 
duration of gene delivery to minutes and low 
retroviral titer was compensated. Moreover, 
they observed a high transfection efficiency in 
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vitro, which was reproduced in vivo using 
magnetic field-guided local transfection of the 
gastrointestinal tract and blood vessels. 
Another in vivo study was performed by 
Kopke et al. [2]. They made middle ear 
implant capable to produce biomechanically 
relevant forces and provide auditory function 
by using superparamagnetic iron oxide 
nanoparticles (SNPs). For this aim, they 
covered oleic acid and dextran coated 
magnetic SNPs with silica and polymer 
materials in order to generate adequate forces 
for pulling nanoparticles across the tissue of in 
vivo models. Subramanian et al. [3] revealed 
increased transfection efficiency in both 
human prenatal cardiac progenitor cells and 
adult cardiomyocytes by oscillating magnet 
array-based nanomagnetic exposure. In an 
experimental and simulation demonstration, 
Lin et al. [4] showed in vitro site-specific gene 
transfection and enhanced efficiency by an 
electric field-assisted electroporation 
microchip. In this study, they revealed that 
plasmid DNA could be delivered at desired 
regions of cells using an electrostatic force. 
According to magnetofection principle, Huang 
et al. [5] developed an innovative 
electroporation (EP) system, which has an EP 
microchip combined with electrophoresis 
(ES). They used a lab-on-a-chip system to 
manipulate adherent cells in situ without 
detachment of the EP-ES microchip and 
showed significant increase in gene 
transfection efficiency by applying attracting 
electromagnetic field. Fung et al. [6] 
investigated cellular internalization efficiency 
of electrodeposited ferromagnetic nickel 
nanowires into 3T3 fibroblast cells in magnetic 
field, and showed the absence of inflammatory 
responses following cellular incubation with 
these nanowires. Namiki et al. [7] showed a 
new nanoparticle formulation composed of 
oleic acid-coated magnetic nanocrystal core 
and a cationic lipid shell, which can be 
magnetically guided to deliver genes more 
efficiently in cells and tumors. Stride et al. [8] 
investigated the effect of both ultrasonically 
and magnetically-mediated DNA transfection 
of Chinese hamster ovary (CHO) cells. They 
compared in vitro uptake of DNA by cells 
exposed to ultrasound and/or a magnetic field 
in the presence of phospholipid coated 
microbubbles prepared with or without a 
suspension of magnetic nanoparticles. The 
results indicated that the transfection 
efficiency was significantly enhanced due to 
simultaneous exposure of cells to ultrasound 
and magnetic field. Kim et al. [9] reported on 
the interfacing of whole cells with 
biocompatible lithographically defined 
ferromagnetic microdiscs with a spin-vortex 
ground state. It was found that spin-vortex-
mediated stimulus caused compromised 
integrity of cellular membranes and initiation 
of programmed cell death. Moreover, the 
authors succeed 90% cancer-cell destruction in 
vitro by applying low-frequency magnetic 
field of few tens of hertz. 
In recent years, there has been much interest in 
using siRNAs and nanoparticles for silencing 
genes for the gene therapy of selected diseases. 
To achieve successful gene silencing using 
siRNA, the molecule must survive in the 
extracellular environment before reaching the 
cell surface, cross the cell membrane and then 
enter RISC complex where unwinding and 
pairing of the antisense strand occur with 
native mRNA. Lee et al. [10] covalently linked 
magnetic nanoparticles to siRNAs, which 
targeted cyclic Arg-Gly-Asp (RGD) peptides 
together with fluorescent dyes to make stable 
simultaneous delivery and multimodal 
imaging. Veiseh et al. [11] reported the 
development of biocompatible, magnetic 
nanovectors for effective intracellular delivery 
of siRNA. They synthesized magnetic 
nanoparticles coated with either pArg or PEI 
and functionalized with siRNA, and showed 
pArg-coated nanovectors most effectively 
knocked-down target genes. 
 
Gene therapy is a promising and developing 
therapeutic method that has the potential to be 
used in the treatment of various diseases, 
including cancer. Development of safe and 
efficient gene delivery systems is still a major 
challenge for the success of gene therapy. 
Here, we designed a specific magnetic 
actuator, which include fundamental features 
such as magnet’s turn speed and magnetic 
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field direction control. For gene delivery via 
magnetic actuation, we used super 
paramagnetic ironoxide nanoparticles (SPION) 
coupled with polyethyleneimine (PEI) and 
assessed DNA uptake efficacy in several cell 
lines derived from different tissues, namely 
MCF-7 (breast), RT-4 (urinary bladder), PC-3 
and DU-145 (prostate) cells. 
 
2. Experimental Setup and Procedure 
 
   Moving a magnetic field without distorting 
its shape is trivial if the source of magnetic 
field can be moved in the same direction. It 
was decided that such a mechanism would be 
cumbersome at best. Instead, the linear 
movement of the magnet was mimicked with 
magnets rotating around a common axis. The 
idea behind this design is using the 
synchronous rotation of symmetric and 
opposing magnets to generate a magnetic field, 
which peaks when the magnets are at the 
closest position and which diminishes while 
the magnets are at the farthest position. Rare 
earth magnets with 300 mT magnetic field 
strength are placed on to the each face of the 
square profile rotors with the (i-1) 9 a mm 
distance from the reference edge, where i is 
the magnet number and a is the magnet 
diameter. The rotors are placed in such a way 
that the tube, which has 3 mm outer diameter, 
stays in between the rotors, which are actuated 
by a simple DC motor. Angular velocities are 
calculated from the position data, which are 
obtained from the encoder of the motor. The 
first design has been improved by reducing the 
angular separation of rare earth magnet pairs 
to obtain higher flow rates, fewer 
discontinuities on the magnetic field, and 
better position tracking. This was achieved by 
changing rectangular rotors into hexagonal 
rotors. 
 
In this experimental investigation, a specific 
magnetic actuator was designed in order to 
accomplish targeted gene delivery of nucleic 
acid-based molecules and it included 
fundamental features such as magnet’s turn 
speed and magnetic field direction control. 
The figure of magnetic actuator is illustrated in 
Fig. 1. The system consists of two magnetic 
rotors, DC motor (12V), power switch, speed 
control switch, power cables, miniature gears 
and proper stand and units for placing cell 
dish. 
 
 
 
 
 
 
Figure 1: Schematics of magnetic actuator 
 
The most important parameter of magnetic 
field requires significantly better control, 
enhanced accuracy to achieve optimal 
magnetic conditions for gene delivery. 
Therefore, the magnetic actuator was designed 
in order to provide improved control ability, 
durability and less system complexity. Thanks 
to miniature gears and speed control switch, 
turn speed of magnetic rotors can be adjustable 
to the desired values. Hence, it provides to 
have control ability of magnetic field force by 
changing rotor speed. On the other hand, the 
direction of magnetic field plays an essential 
role. In order to supply continuous magnetic 
field, each magnets on the magnetic rotors are 
transversely placed. Hence the system 
provides magnetic field in both vertical and 
horizontal directions due to magnetic vortexes 
which is shown in Fig. 2. 
 
DC Motor (12V) Speed Control 
Switch 
Magnetic Rotors
Miniature Gears Power cables 
Magnets
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Figure 2: Magnetic field direction on 
magnetic rotors 
 
2.1 Preparation of polyethyleneimine-
superparamagnetic nanoparticles (PEI-
SPION)  
Polyethyleneimine-superparamagnetic 
nanoparticles (PEI-SPION) were kindly 
provided from Koç University, Department of 
Chemistry, Turkey. In brief, oleic acid coated 
Fe3O4 nanoparticles were obtained from the 
Ocean NanoTech LLC. The hydrophobic 
Fe3O4 nanoparticles were silica coated by a 
modified reverse micro emulsion procedure by 
using tetraethyl orthosilicate. 
Polyethyleneimine (PEI) was added to the 
surface of the Fe3O4-SiO2 nanoparticles by 
stirring with trimethoxysilylpropyl modified 
polyethyleneimine (50% in isopropanol).  
 
2.2 Plasmid DNA isolation 
Plasmid DNA isolation was performed with 
plasmid DNA purification kit according to 
manufacturers instructions (Nucleobond Xtra 
Midi/Maxi, Macherey-Nagel, Germany). 
pMAX-GFP (Addgene, Cambridge, USA) 
plasmid was used for transfection tests. 
 
2.3 Cell Culture 
MCF-7, human breast cancer cell line, PC-3 
and DU-145, human prostate cancer cells were 
cultured in DMEM (Sigma, Germany) 
supplemented with 10% FBS (Biochrom KG, 
Germany), 1% Penicillin-Streptomycin 
(Biological Industries, Israel), 1% L-glutamine 
(Biological Industries, Israel). RT-4, urinary 
bladder cancer cells were cultured in McCoy’s 
(Biochrom KG, Germany) complete medium. 
1, 5 x 106 cells were seeded on 10-cm culture 
plate in 10 ml cell culture medium. Cells were 
incubated at 37°C in a 5% CO2 atmosphere. 
 
2.4 DNA Transfection and Microscopic 
Analyses  
According to the cell type 15-40 µg of PEI or 
PEI-SPION was added into eppendorf tube 
containing 100 µl DMEM or McCoy’s 
(without serum and antibiotics). In another 
eppendorf tube, 5 µg of pMAX-GFP was 
mixed with 100 µl DMEM or McCoy’s 
(without serum and antibiotics). Contents of 
the tubes were mixed and vortexed for 15 
seconds. Following 10 min. incubation at room 
temperature, the mixture was added dropwise 
onto 10cm culture plates. Cells were washed 
with PBS after 6-8 hours and incubation was 
continued in DMEM or McCoy’s 
supplemented with 10% FBS, 1% Penicillin-
Streptomycin and 1% L-glutamine. At 48 h 
post-transfection, cells were stained by 
addition of 1µg/µl Hoechst 33342 (Life 
Technologies, USA) and further incubation for 
30 min., and then analyzed under a fluorescent 
microscope (Olympus BX60). 
. 
3. Results and Discussion 
 
3.1 PEI Transfection Results 
PEI is one of the most widely and most 
successfully used polymers used for nucleic 
acid delivery. However, high transfection 
efficiencies might be associated with toxicity. 
To assess gene delivery efficiency of SPION-
coupled-PEI via magnetic actuation, we first 
performed some control experiments with 
naked PEI. We transfected MCF-7, PC-3, DU-
145 and RT-4 cells, with different ratios of 
GFP-tagged DNA and PEI molecules in order 
to obtain maximum transfection efficiency 
with minimal toxicity. Maximum transfection 
efficiency was obtained using 2.5 µg DNA 
with 20 µg PEI for PC-3 and DU-145 cells. 
For MCF-7 and RT-4 cells, best transfection 
ratios were achieved using 35µg and 15µg 
PEI, respectively. (Fig.3 left two panel and 
Fig.4). As seen under phase-contrast 
microscope images, under our experimental 
conditions, we did not observe any significant 
toxicity. Yet, usage of PEI amounts more than 
35µg caused dramatic cell death in four 
different cancer cell lines. 
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Figure 4: PEI/PEI-SPION transfection 
efficiency under magnetic or non-magnetic 
conditions in MCF-7, PC-3, DU-145 and RT-4 
cell lines. Data are shown as mean  ±S.D. (n 
= 3),  (*p < 0.05) 
 
In order to investigate effect of varying 
magnetic fields on targeted gene delivery of 
nucleic acid-based molecules, experiments are 
conducted using the miniature magnetic  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
actuation device under various test conditions. 
Accordingly, the experimental tests are 
performed with different magnetic rotor turn 
velocities varying from 0.108 to 0.216 m/s 
when the supplied voltage was 12 V and 
currents were 2.1 Amp and 4.2 Amp, 
respectively. In order to assess the relationship 
between magnetic rotor velocity and supplied 
power, calculated voltage/current curve is 
given in Fig. 5. 
 
 
 
Figure 5: Power vs velocity curve for 
magnetic rotors 
Figure 3: PEI transfection with or without SPION under magnetic or non-magnetic conditions in 
MCF-7, PC-3, DU-145 and RT-4 cell lines. 2.5µg/µl GFP-tagged DNA was used in combination 
with 20µg PEI for PC-3 and DU-145, 35µg  for MCF-7,  15µg for RT-4 cells (Left two panel).  
For  PEI-SPION transfection, 6µg PEI-SPION/5µg DNA was used under magnetic and non-
magnetic conditions. 48h after transfection, cell images was taken by using inverted fluorescent 
microscope 
Cell dish
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Figure 6: Magnetic field alteration for 
different rotor velocities 
 
The use of PEI-SPION (Super paramagnetic 
iron oxide nanoparticles) as transfection agents 
was investigated with the effect of varying 
magnetic fields provided by a special magnetic 
system design, which was used as magnetic 
actuator offering different magnet's turn 
speeds in the system. PEI complexes bind to 
DNA via the electrostatic binding interaction 
between secondary amine groups of PEI and 
phosphate backbone of DNA. On the other 
hand, PEI complexes bind to DNA via the 
electrostatic binding interaction between 
secondary amine groups of PEI and phosphate 
backbone of DNA [12]. In the relevant 
literature [13], it was showed that silica layer 
over iron oxide core can easily bind to amine 
groups of PEI with amine-to-silica interaction. 
In order to assess magnetic field effect, we 
first performed a concentration test for PEI-
SPION and the concentration, which gives 
maximum transfection efficiency (6µg PEI-
SPION/5µg DNA) without any toxicity is used 
for further experiments. All cancer cells 
exposed with or without magnetic field for 6 
hours then washed with PBS and continue to 
culture for additional 42 hours. Results were 
obtained via miniature magnetic actuation 
device. Significant enhancements for targeted 
gene delivery were attained for all cell types 
when compared with non-magnetic field 
conditions. (Fig. 3 last four panel and Fig. 4). 
However, when we compared with single PEI, 
PEI-SPION has much lower transfection 
efficiency. The results indicated that, PEI-
SPION can be successfully used for gene 
delivery in MCF-7, PC-3, DU-145 and RT-4 
cell lines. 
 
In previous studies, PEG 
(Polyethyleneglycol)-PEI-SPION was used for 
transfection agent in SGC-7901 (Human 
Gastric Carcinoma) cell line [35]. This work 
showed that PEGylated-PEI-SPION can be 
perfect candidate for gene delivery of nucleic 
acid based molecules as being transfection 
agents in in vitro studies. In addition of this, 
here we showed PEI-SPION could also be a 
perfect candidate without any modification 
such as PEGylation. SPIONs could be 
concentrated at certain region such as tumors 
because of their magnetic nature. Beside, 
magnetic nanoparticles could be used as 
hyperthermia treatment. They cause local 
temperature increase which may also be used 
as an alternative and efficient cancer therapy. 
Therefore, increased gene delivery efficiency 
with magnetic field that we showed here could 
be turned to alternative treatment approach for 
cancer therapy. 
 
4. Conclusions 
 
In this study, a platform for gene delivery 
via magnetic actuation of nanoparticles was 
developed. PEI-SPION (Super paramagnetic 
iron oxide nanoparticles) was investigated as 
transfection agents in in vitro studies with the 
effect of varying magnetic fields offered by a 
miniature magnetic actuator design. The 
proposed device could be used as magnetic 
actuator, which offers different magnet’s turn 
speed and directions. The major findings of 
this study are as follows: 
 
• PEI-transfection was optimized 
without any toxicity effect in four 
different cancer cell lines (MCF-7, PC-
3, DU-145, RT-4) and transfection 
efficiency was obtained up to 45 %. 
• PEI-SPION molecules can be 
successfully used for nucleic-acid 
based gene delivery and magnetic field 
exposure can improve the delivery 
efficiency.  
• Higher magnet’s turn speed result in 
higher transfection rate. 
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• Transfection rate is independent from 
magnet’s turn direction. 
• It is proven that the miniature magnetic 
actuator setup could be used for 
investigation of transfection agents in 
in vitro and in vivo studies. 
• It is proven that the miniature magnetic 
actuator could deliver drug and genes 
to the targeted cell having low energy 
consumption, low waste disposal, and 
parallel and fast processing capacity, 
high mixing capability, enhanced 
safety and low amount of reagents. 
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